This study provides evidence that elevated NLRP3/IL‐1β expression promoted the progression of oxaliplatin‐resistant HCC by inducing PD‐L1 upregulation as well as recruitment of PMN‐MDSCs. Here, NLRP3 is linked to hepatocellular carcinoma.